Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study PXN110748: An Efficacy and Safety Study of XP13512 Compared With a Concurrent Placebo Control in Subjects With Neuropathic Pain Associated With Post-herpetic Neuralgia (PHN)

NCT00619476 is registered in ClinicalTrials.gov with XenoPort, Inc. as lead sponsor.

NCT NCT00619476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study PXN110748: An Efficacy and Safety Study of XP13512 Compared With a Concurrent Placebo Control in Subjects With Neuropathic Pain Associated With Post-herpetic Neuralgia (PHN)
Lead sponsor
XenoPort, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
July 31, 2009
Enrollment
376 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

neuralgia, postherpetic